Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations ("Evolent Health"), today announced the pricing of a secondary public offering of 7,500,000 shares of its Class A common stock to be sold by UPMC, certain affiliates of TPG Global, LLC, The Advisory Board Company and Ptolemy Capital, LLC (together, the "Investor Stockholders") and certain management selling stockholders (the "Management Stockholders" and together with the Investor Stockholders, the "Selling Stockholders"). The shares of Class A common stock are being sold to the public at a price of $22.50 per share. The offering was upsized from the previously announced offering size of 7,000,000 shares of Class A common stock. The underwriters have a 30-day option period to purchase up to 1,125,000 additional shares of Class A common stock from the Investor Stockholders. The offering is expected to close on September 14, 2016, subject to customary closing conditions.

J.P. Morgan Securities LLC and Goldman, Sachs & Co. are acting as joint book-running managers for the offering. Wells Fargo Securities, LLC, William Blair & Company, L.L.C., SunTrust Robinson Humphrey, Inc., Allen & Company LLC, Cowen and Company, LLC and Leerink Partners LLC are acting as co-managers.

About Evolent Health

Evolent Health partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent Health helps physicians and health systems achieve superior quality and cost results. Evolent Health's approach breaks down barriers, aligns incentives and powers a new model of care delivery resulting in meaningful alignment between providers, payers, physicians and patients.